Elevated-TG Cohorta (n = 23,181) | Comparator Cohorta (n = 23,181) | P Value | |
---|---|---|---|
Age, mean (SD), years | 62.2 (9.6) | 62.6 (9.9) | <0.001 |
Female, n (%) | 11,518 (49.7) | 11,467 (49.5) | 0.244 |
Insurance type, n (%) | |||
Commercial | 15,823 (68.3) | 15,855 (68.4) | 0.461 |
Medicare | 7358 (31.7) | 7326 (31.6) | 0.461 |
Duration of follow-up, mean (SD), months | 41.4 (23.7) | 42.5 (23.9) | <0.001 |
Baselineb lipid profile, mean (SD), mg/dL | |||
TG | 220.31 (77.4) | 97.9 (28.9) | <0.001 |
LDL-C | 104.6 (41.1) | 100.9 (35.0) | <0.001 |
HDL-C | 42.3 (10.2) | 55.1 (12.2) | <0.001 |
Total cholesterol | 190.2 (46.6) | 175.4 (38.8) | <0.001 |
Non-HDL-Cc | 147.9 (44.2) | 120.4 (36.5) | <0.001 |
Baseline comorbidities, n (%) | |||
Diabetes | 19,392 (83.7) | 19,478 (84.0) | 0.017 |
ASCVD | 6915 (29.8) | 6800 (29.3) | 0.009 |
MI | 495 (2.1) | 411 (1.8) | 0.003 |
Stroke | 750 (3.2) | 674 (2.9) | 0.005 |
Angina | 1225 (5.3) | 1179 (5.1) | 0.284 |
Coronary revascularization | 600 (2.6) | 506 (2.2) | 0.002 |
Peripheral artery disease | 3384 (14.6) | 3317 (14.3) | 0.104 |
Heart failure | 1258 (5.4) | 1088 (4.7) | <0.001 |
Atrial fibrillation | 1133 (4.9) | 989 (4.3) | 0.001 |
Hypertension | 18,346 (79.1) | 18,375 (79.3) | 0.462 |
Renal disease | 2832 (12.2) | 2782 (12.0) | 0.196 |